Brainstorm Cell Therapeutics Inc. Gains 22.67%
Tue 18 Feb 20 at 05:30 PM
Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ) jumped higher at $6.33, representing a gain of 22.7%. On Mon 17 Feb 20, BCLI:NASDAQ touched a New 2-Week Intraday High of $5.79. The stock appeared on our News Catalysts scanner on Tue 18 Feb 20 at 07:43 AM in the 'EARNINGS' category. From Mon 27 Jan 20, the stock recorded 42.86% Up Days and 33.33% Green Days
About Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ)
Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.
Top 10 Gainers:
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 168.37%
- Wanda Sports Group Company Limited (WSG:NASDAQ), 45.48%
- Brickell Biotech, Inc. (BBI:NASDAQ), 42.24%
- Zovio Inc (ZVO:NASDAQ), 30.49%
- Intelsat S.A. (I:NYSE), 25.81%
- Legg Mason, Inc. (LM:NYSE), 24.41%
- Lilis Energy, Inc. (LLEX:NYSEMKT), 23.93%
- Senseonics Holdings, Inc. (SENS:NYSEMKT), 23.85%
- InflaRx N.V. (IFRX:NASDAQ), 23.6%
- Brainstorm Cell Therapeutics Inc. (BCLI:NASDAQ), 22.67%